city Oxford: Latest News

All news where city Oxford is mentioned

cidrap.umn.edu

22.02.2021 / 23:58

Delaying 2nd AstraZeneca COVID shot may boost efficacy

A single dose of the AstraZeneca/Oxford vaccine offered 76% protection against COVID-19 for 3 months, at which time administering the second dose resulted in up to 47% greater protection than giving it at 6 weeks, according to a study published late last week in the Lancet.

Britain South Africa Brazil city Oxford covid-19 testing vaccine Coronavirus

Covid vaccine hailed by Scots study as one dose reduces risk of hospitalisation

vaccination programme has been linked to a substantial reduction in hospital admissions north of the border.Researchers examined coronavirus hospital admissions in Scotland among people who have had their first jab and compared them with those who had not yet received a dose of the vaccine.Experts from rom the University of Edinburgh, the University of Strathclyde and Public Health Scotland examined data on people who had received either the Pfizer/BioNTech jab or the one developed by experts at the University of Oxford with AstraZeneca.By the fourth week after receiving the initial dose, the Pfizer and Oxford/AstraZeneca vaccines were shown to reduce the risk of hospital admission from Covid-19 by up to 85% and 94%, respectively, they

Scotland city Oxford hospital vaccine Coronavirus

New tech to pick out people at high Covid-19 risk in England for vaccines

London: A new risk-prediction model devised by Oxford University scientists is to be deployed as new technology by the National Health Service (NHS) in England to help clinicians identify a new group of people who may be at high risk from COVID-19.Over 800,000 adults will now be prioritised to receive a vaccine as part of the current vaccination cohorts, combining several health and personal factors, such as age, ethnicity and body mass index (BMI), as well as certain medical conditions and treatments.The University of Oxford turned its research into a risk prediction model called QCovid, which has been independently validated by the Office for National Statistics (ONS) and is pegged as the only COVID-19 risk prediction model in the world

city Oxford covid-19 vaccine

manchestereveningnews.co.uk

16.02.2021 / 14:27

72%

592

Early research into vaccine effect on Covid-19 transmission 'really encouraging' says minister

restrictions can be cautiously eased in the coming weeks, saying vaccines are providing “grounds for confidence”.

city Manchester city Oxford hospital death vaccine

How the UK rolled out successful mass vaccine programme

Despite stark failures in curbing Covid-19's spread, the UK has scored a notable success with its mass vaccination drive, giving 15 million people a first dose by this weekend.

Margaret Keenan Britain Eu city Oxford World UK Coronavirus

The Latest: Oxford University testing vaccine in children

LONDON — The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people.

Andrew Pollard city Oxford covid-19 testing vaccine

Coronavirus cases fall sharply in a week with 1 in 80 now infected in England

One in 80 people in England have Covid as infections decrease in all but one region, according to the latest official figures.

Ireland Scotland city Manchester city Oxford covid-19 testing infection fall

Tocilizumab cuts death rate in severe COVID-19, study finds

Hospitalized COVID-19 patients given the anti-inflammatory monoclonal antibody tocilizumab were less likely to die or require invasive mechanical ventilation, according to preliminary results of the UK RECOVERY trial posted today on the medRxiv preprint server.

Britain city Oxford covid-19 Ventilators patient

Giving coronavirus jab to schoolkids is 'key to avoiding lockdowns', expert says

A top health official has suggested vaccinating children this year to avoid further lockdowns.

Jeremy Farrar city Oxford pandemic vaccine Coronavirus

AstraZeneca expects new version of COVID-19 vaccine by autumn

AstraZeneca said Thursday it expects to have a new version of its COVID-19 vaccine ready for use by this autumn as drugmakers respond to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines.The Anglo-Swedish company, which makes a vaccine developed by the University of Oxford, said it is working with the university’s scientists to adapt the shot to combat new variants. Researchers began this work months ago when the variants were first detected, said Mene Pangalos, head of biopharmaceuticals research for AstraZeneca.

Sweden city Oxford Coronavirus Vaccine COVID-19 Vaccine Coronavirus

AstraZeneca expects updated Covid-19 vaccine by autumn to fight virus strains

London: AstraZeneca said Thursday it expects to have a new version of its COVID-19 vaccine ready for use by this autumn as drugmakers respond to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines.The Anglo-Swedish company, which makes a vaccine developed by the University of Oxford, said it is working with the university's scientists to adapt the shot to combat new variants.

Sweden city Oxford covid-19 death vaccine

Covid-19 updates: Germany plans gradual reopening of economy

German Chancellor Angela Merkel wants a gradual reopening of shuttered stores and hotels next month as long as the coronavirus infection rate continues to fall in Europe’s biggest economy.Passengers traveling to the UK will face tougher quarantine measures, including enforced stays in hotels, repeated tests and the threat of fines as authorities seek to get a grip on the coronavirus pandemic.Also Read | Inside the third front of the farm agitationHong Kong’s government will hold a press conference on the Covid-19 situation later Wednesday. South Korea cleared AstraZeneca Plc’s and the University of Oxford’s vaccine for all adults, including the elderly.BioNTech’s New Factory Starts Production (3:51 p.m. HK)BioNTech started producing

Angela Merkel South Korea Germany Britain city Oxford vaccine Government Coronavirus Updates

AstraZeneca’s Covid shot still useful in variant-hit areas: WHO

AstraZeneca Plc’s Covid-19 vaccine is worth using in areas hit by mutated strains of the virus, World Health Organization officials and partners said, countering concerns about reduced effectiveness that arose in a recent test.There’s evidence the vaccine AstraZeneca developed with the University of Oxford could provide meaningful protection against severe disease caused by the highly infectious variant that emerged in South Africa, called B.1.351, according to Kate O’Brien, who heads the WHO’s vaccination division.

Kate Obrien South Korea India South Africa city Oxford virus covid-19 vaccine

South Africa suspends use of AstraZeneca's COVID-19 vaccine after it fails to clearly stop virus variant

Jon CohenScience's COVID-19 reporting is supported by the Heising-Simons Foundation.Another COVID-19 vaccine has run into trouble in South Africa, showing less protection there than elsewhere because a SARS-CoV-2 variant that can apparently dodge key antibodies has become widespread.

South Africa city Oxford covid-19 vaccine infection

AstraZeneca’s coronavirus vaccine may reduce virus transmission, developers say

AstraZeneca’s COVID-19 vaccine shows a hint that it may reduce transmission of the virus and offers strong protection for three months on just a single dose, researchers said Wednesday in an encouraging turn in the campaign to suppress the outbreak.The preliminary findings from Oxford University, a co-developer of the vaccine, could vindicate the British government’s controversial strategy of delaying the second shot for up to 12 weeks so that more people can be quickly given the first dose.

Britain city Oxford vaccine Coronavirus

Oxford, Pfizer Covid vaccines to be combined in trial: 10 things to know

coronavirus vaccines.The University of Oxford is set to begin a trial combining vaccines against the novel coronavirus from AstraZeneca and Pfizer in a two-shot schedule to assess the immune responses generated from the doses.Also Read | The health nudge is merely a mirageParticipants in the UK government-funded study will reportedly get one shot of AstraZeneca's Covid-19 vaccine followed by a dose from Pfizer, or vice versa.Here's your 10-point cheatsheet to this story:1) The Oxford University will begin recruiting 820 participants over 50 years of age across eight Britain sites this week, as per a statement.

Britain city Oxford covid-19 vaccine Coronavirus

Oxford to run trial alternating Covid-19 vaccines

Also Read | The health nudge is merely a mirageBritain, the first western nation to launch its vaccination programme, has bucked the international trend by administering vaccines at an interval of 12 weeks in a bid to give a first dose of the vaccine to more individuals.Professor Matthew Snape from Oxford University called the study "extremely exciting", adding that it would provide "information vital to the roll out of vaccines in the UK and globally".If the study shows positive results, Britain's independent medicines regulator would formally assess the safety and efficacy of any new vaccination regimen before it is rolled out to patients.Disagreements between the UK and the European Union over vaccine supplies have boiled over in recent

Britain Eu city Oxford covid-19 vaccine

Study finds COVID-19 vaccine may reduce virus transmission

AstraZeneca’s COVID-19 vaccine does more than prevent people from falling seriously ill — it appears to reduce transmission of the virus and offers strong protection for three months on just a single dose, researchers said Wednesday in an encouraging turn in the campaign to suppress the outbreak.

Britain city Oxford virus covid-19 vaccine

Oxford vaccine cutting Covid transmission rates by 67 per cent 'may be holy grail'

A top scientist has said that the Oxford/AstraZeneca vaccine could prove to be the "holy grail" the world needs - after data showed it appears to cut transmission rates by two thirds.

city Oxford virus vaccine medicines

manchestereveningnews.co.uk

03.02.2021 / 02:03

94%

370

Study claims Oxford coronavirus jab protects for 12 weeks after single dose and may cut transmission

direct to your inboxThe University of Oxford’s coronavirus vaccine offers protection of 76% up to 12 weeks after a single dose and may reduce transmission by 67%, according to a new study.After the second dose, vaccine efficacy from two standard doses is 82.4% with the three-month interval being used in the UK, researchers from the University of Oxford say.The data from the study, which has not yet been peer reviewed, supports the four to 12-week prime-boost dosing interval that many global regulators have recommended.Analyses of positive coronavirus swabs in the UK population suggest the vaccine may have a substantial effect on transmission of the virus, with a 67% reduction in positive swabs among those vaccinated with the

Britain city Oxford vaccine Coronavirus

Oxford/AstraZeneca vaccine protects 12 weeks after single dose - study

The University of Oxford's coronavirus vaccine offers protection of 76% up to 12 weeks after a single dose and may reduce transmission by 67%, according to a new study.

Britain city Oxford World UK Coronavirus

Oxford-AstraZeneca didn’t tell vaccine trial volunteers about dosing mishap

Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren’t informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.Instead, the dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses. The letter was signed by the trial’s chief investigator, Oxford professor Andrew J.

city Oxford Coronavirus Vaccine Coronavirus

Early signs suggest delaying second Covid vaccine dose to 12 weeks was 'right'

Early signs suggest the UK strategy of delaying the second Covid-19 jab was the right decision, a top Government vaccine adviser has said.

Anthony Harnden Britain city Oxford covid-19 vaccine Government

Pfizer wants India to order its COVID vaccine before taking regulatory process forward: Report

New Delhi: Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the U.S. drugmaker told Reuters on Monday, even as global supplies tighten.Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots - one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.India's Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company's application was made in early December.

city New Delhi India city Oxford covid-19 vaccine Government

Oxford University plans trials of ‘wonder drug’ that may reduce covid deaths

Covid-19 deaths globally, according to a report in the Times.The goal is to find treatments that could be used at home, shortly after symptoms appear, to catch the disease early and prevent serious illness.This batch of medicines will include ivermectin, which for decades has been used to treat livestock and people infested with parasitic worms, the newspaper reported. Supporters call it a “wonder drug," but others say it hasn’t been properly evaluated.While the drug has potential antiviral and anti-inflammatory properties, “there’s a gap in the data," Chris Butler, professor of primary care at the University of Oxford and a co-chief of the trial, told the Times.

city Oxford covid-19 death

South Africa authorities approve Serum Institute of India's COVID-19 vaccine

Johannesburg: South Africa's health regulatory body has granted approval to the world's largest drug manufacturer Serum Institute of India (SII) to supply COVID-19 vaccine to the country.Health Minister Zweli Mkhize announced on Friday that the South African Health Products Regulatory Authority (SAHPRA) has granted approval to the SII, which is producing the vaccine in collaboration with the University of Oxford and AstraZeneca, to supply the drug to the country.The approval comes amid growing concerns that the 1.5 million vaccine doses to be shipped to South Africa in the next few weeks had not been approved by the local regulator.“We will, in the next coming days, engage with the public in order to give an update on the progress of the

Zweli Mkhize India South Africa city Johannesburg city Oxford covid-19 vaccine

Brazil announces incoming 2 million Covid vaccine doses from India amid supply concerns

Oxford coronavirus vaccine was finally set to arrive in the country from India.The Covid-19 vaccine delivery comes as public health experts sound the alarm over insufficient supply in South America's biggest nation.The vaccine, developed by AstraZeneca and the University of Oxford, will clear customs in Sao Paulo on Friday before being flown to Rio de Janeiro, where Brazil's state-run Fiocruz Institute is based, the ministry said.

India city Rio De Janeiro Brazil city Sao Paulo city Oxford vaccine Government Coronavirus

Coronavirus: 4 deaths, 86 cases in London-Middlesex; 2 deaths in Huron-Perth, 1 in Elgin-Oxford

coronavirus, officials with the Middlesex-London Health Unit reported on Wednesday.The update brings the region’s pandemic case tally to 5,233, of which 3,559 have recovered, an increase of 30 from the day before.To date, at least 160 people have died.

city London county Huron city Elgin city Oxford covid-19 Coronavirus

One in 11 Scots has been infected with virus as UK covid deaths exceed 106,000 figure

coronavirus according to the latest figures.

Britain Scotland city Manchester city Oxford virus covid-19 death

New coronavirus variants could cause more reinfections, require updated vaccines

Kai KupferschmidtScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.When the number of COVID-19 cases began to rise again in Manaus, Brazil, in December 2020, Nuno Faria was stunned. The epidemiologist at the University of Oxford had just co-authored a paper in Science estimating that three-quarters of the city’s inhabitants had already been infected with SARS-CoV-2, the pandemic coronavirus—more than enough, it seemed, for herd immunity to develop.

state Indiana Brazil city Oxford virus covid-19 vaccine

Covishield: How effective is it against novel COVID-19? What we know so far

COVID-19 vaccine drive via video conferencing at 10.30 am on Saturday.India approved the emergency authorisation of two vaccines against novel coronavirus — Covaxin by Bharat Biotech and Covishield by Serum Institute of India. Earlier, Britain and Argentina had approved the emergency marker use of coronavirus vaccine developed by the University of Oxford and AstraZeneca.

India Britain Argentina Sweden city Oxford covid-19 vaccine Coronavirus

A day to remember: London nursing home greets virus vaccine

LONDON – In 1948, John Peake won a silver medal at the Olympic Games in London. In 2021, also in London, he struck what many would consider gold, receiving his first dose of a coronavirus vaccine.Amid growing concerns over rising COVID outbreaks at nursing homes in Britain, the 96-year-old was one of the 45 residents at Wimbledon Beaumont Care Community in southwest London to receive the vaccine Wednesday developed by the University of Oxford and British pharmaceutical company AstraZeneca.“I’m glad to have it and I appreciate the fact that it has come to this place early,” he told The Associated Press after receiving his jab.

Britain city London city Oxford virus vaccine Coronavirus

Serum Institute of India hopes to launch a COVID-19 vaccine every quarter: CEO

Reuters reported. Pune-based drugmaker joined hands with British-Swedish pharma giant AstraZeneca to manufacture 1 billion doses of COVID-19 vaccine developed by the University of Oxford.

India Sweden city Pune city Oxford covid-19 vaccine

Coronavirus: 2 deaths, 120 new cases in London-Middlesex; 2 deaths, 40 cases in Elgin-Oxford

coronavirus in London and Middlesex, local health officials reported on Wednesday.The update, which is at least the seventh time this month the region has seen a triple-digit case increase, brings the region’s case total to 4,710, of which 3,212 people have recovered, 55 more than the day before.At least 134 people have died.

city London county Middlesex city Elgin city Oxford covid-19 coronavirus news Coronavirus

South Africa to get Serum-made 1.5 mn COVID-19 vaccines from India

Johannesburg: South Africa will receive one million COVID-19 vaccines from the Pune-based Serum Institute of India this month, followed by an additional 500,000 doses in February, the health minister told Parliament on Thursday, amid a spike in coronavirus deaths and infections in the country.Drug major AstraZeneca has partnered with the Serum Institute of India (SII), the world's largest vaccine manufacturer, for the supply of the vaccine to the Indian government and also to a large number of low and middle-income countries.The vaccine, developed with the University of Oxford, is made from a virus which is a weakened version of a common cold virus (adenovirus), that has been genetically changed so that it is impossible for it to grow in

India South Africa city Johannesburg city Pune city Oxford covid-19 vaccine

COVID-19 vaccine Covishield by Serum Institute: How effective is it? How much will it cost?

Covaxin by Bharat Biotech and Covishield by Serum Institute of India. Earlier, Britain and Argentina had approved the emergency marker use of coronavirus vaccine developed by the University of Oxford and AstraZeneca.

India Britain Argentina Sweden city Oxford covid-19 vaccine Coronavirus

Coronavirus: U.K. administers 1st shots of AstraZeneca-Oxford vaccine

Britain on Monday took another giant step in the fight against COVID-19, ramping up its immunization program by giving the first shots in the world from the vaccine created by Oxford University and pharmaceutical giant AstraZeneca.

Britain city Oxford covid-19 vaccine Coronavirus

manchestereveningnews.co.uk

04.01.2021 / 12:37

74%

322

Army drafted into Greater Manchester from today to help with Covid-19 testing in 'biggest homeland operation in peacetime'

direct to your inboxThe Army is being drafted into Greater Manchester from today to help carry out 'targeted' asymptomatic testing for coronavirus, the government has announced.The Ministry of Defence said 800 military personnel including soldiers would deploy to support community testing plans drawn up by Greater Manchester Combined Authority.The news comes as the latest Covid-19 vaccine - from Oxford AstraZeneca - was administered for the first time on Monday.The MOD said personnel from nine regiments of the British Army would be involved in the operation in Greater Manchester, working across all 10 boroughs.Those said to be at a higher risk of infection - from social care staff to people with 'public facing' jobs like bus drivers - will

Britain city Manchester city Oxford covid-19 testing Coronavirus

Covid vaccine: Brian Pinker, 82, becomes first person to receive Oxford vaccine in UK

vaccine created by Oxford University and pharmaceutical giant AstraZeneca.82-year-old dialysis patient, Brian Pinker, became the first person to be administered its dose at a hospital in Oxford as Britain began inoculating its citizens.Also Read | A year on, China is shaking up the worldPinker said he was so pleased and that he can "now really look forward to celebrating my 48th wedding anniversary with my wife Shirley later this year."Britain has become the first country to roll out the low cost and easily transportable AstraZeneca and Oxford University vaccine against the novel coronavirus on Monday, another step forward in the global response to the pandemic.Govt hopes to deliver tens of millions of dosesSix hospitals in England will

China Britain county Oxford city Oxford virus vaccine Government

The Latest: German governor: Extend lockdown through January

India has approved two COVID-19 vaccines, paving the way for a massive inoculation program. The vaccines are from Oxford University and AstraZeneca and local firm Bharat Biotech.— Britain faces mounting pressure from the teachers to keep schools closed in England as it hit a record of more than 57,000 daily coronavirus cases.

Yuriko Koike India Germany Britain city Tokyo state Ohio city Oxford vaccine Coronavirus

manchestereveningnews.co.uk

03.01.2021 / 09:23

64%

175

Oxford coronavirus vaccines start to arrive at hospitals across UK as first patients to receive jab on Monday

direct to your inboxBatches of the newly approved coronavirus vaccine from Oxford University and AstraZeneca have started arriving at hospitals ahead of the jab’s rollout.Some 530,000 doses of the vaccine will be available for rollout across the UK from Monday, with vulnerable groups already identified as the priority for immunisation.The NHS will be the first health service in the world to deliver the jab, which was approved last week, in the next stage of the phased vaccine programme.The first Oxford AstraZeneca vaccinations will be delivered at a small number of hospitals for the first few days for surveillance purposes before the bulk of supplies are sent to hundreds of GP-led services later in the week.Oxford University Hospitals NHS

Britain city Oxford hospital vaccine NHS Coronavirus

Britain is first country to approve Oxford-AstraZeneca’s COVID-19 vaccine

The United Kingdom has become the first country to approve the COVID-19 vaccine from Oxford University and pharmaceutical company AstraZeneca. Redmond Shannon explains what makes this vaccine different from the others.

Britain city Redmond, county Shannon county Shannon city Oxford covid-19 vaccine

Coronavirus vaccine: Who will get new Oxford-AstraZeneca jab and when?

coronavirus vaccine developed by the University of Oxford and AstraZeneca has finally been approved for use in the UK.

Matt Hancock Britain city Oxford vaccine Coronavirus

Amid 1k Covid deaths in a day, Germany expects quick EU nod for Oxford vaccine

Germany expects the European Union to give quick approval to the Oxford coronavirus vaccine as daily Covid-19 deaths has crosses 1,000 for the first time on Wednesday.However, the European Medicines Agency is unlikely to approve it in January, the regulator's deputy executive director Noel Walthion told Belgian newspaper Het Nieuwsblad on Tuesday.

Germany Eu Belgium city Oxford death vaccine infection Coronavirus

manchestereveningnews.co.uk

30.12.2020 / 10:41

68%

470

Oxford University and AstraZeneca Covid-19 vaccine approved for use in the UK

direct to your inboxA Covid-19 vaccine from Oxford University and AstraZeneca has been approved for use in the UK, paving the way for rapid rollout, the Department of Health said.Health Secretary Matt Hancock said the approval of the Oxford vaccine was “fantastic news” and confirmed that the rollout would begin on Monday, January 4.In a tweet, he said the vaccine was 'our way out of the pandemic'.He wrote: "Brilliant to end 2020 with such a moment of hope: the @UniofOxford / @AstraZeneca#coronavirus vaccine has today been authorised for use by @mhragovuk.

Matt Hancock Britain city Oxford covid-19 vaccine NHS

Oxford/AstraZeneca Covid-19 vaccine approved in UK

A Covid-19 vaccine from Oxford University and AstraZeneca has been approved for use in the UK, paving the way for mass rollout.

Britain city Oxford World UK Coronavirus

AstraZeneca Covid vaccine has 'winning formula': CEO

The Covid-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said.

Pascal Soriot Britain city Oxford World Coronavirus

AstraZeneca Covid vaccine has 'winning formula' for efficacy: CEO Soriot

Covid-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said on Sunday.The vaccine, which is currently being evaluated by Britain's independent medicines regulator, provides "100% protection" against severe Covid disease requiring hospitalisation, Pascal Soriot said in an interview.He added he believes trials will show his firm has achieved a vaccine efficacy equal to Pfizer-BioNTech at 95% and Moderna at 94.5%."We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else," the chief executive said explaining data would be published at "some point".The UK

Pascal Soriot Britain city Oxford vaccine Government medicines

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0